Language: BG BG
← Back to results
Recruiting Not applicable NCT04998175

Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)

No applicable phase (e.g. observational)
Conditions: Idiopathic Normal Pressure Hydrocephalus

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

trial.available_in: БГ
Overview
The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics research
Description
Preoperative T1-MRI, functional MRI and diffusion MRI imaging data of iNPH patients were collected. The clinical assessment was performed before/after the lumbar puncture test and 6 months after VP shunt. Clinical assessment included Mini-mental State Examination (MMSE), gait scores, Kiefer score, and Modified Rankin Scale (mRS). The cerebrospinal fluid was collected by tap-test, and 6 months after surgery by puncturing in the VP device pump. Methods- The primary methods used are: 1. The cerebrospinal fluid proteomic analysis of iNPH patients before and after VP shunt surgery. 2. The structral and functional MRI analysis of iNPH patients 3. The clinical assessment of MMSE, gait scores, Kiefer score, and mRS. Objective- To study the prognostic factors of VP shunt for iNPH.
Who can participate
Inclusion Criteria: * Age ≥ 60 years; * Diagnosis of iNPH based on clinical assessment * Participant is able to give written informed consent Exclusion Criteria: * Combining AD and Parkinson's disease and other nervous system diseases * Participant is not medically available for shunt surgery * Secondary NPH
Interventions
ventriculo-peritoneal shunt
PROCEDURE
Locations 1
China (1)
The second affliated hospital of zhejiang university
Hangzhou , Zhejiang
Technical details
Status
Recruiting
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
60 Years
Maximum age
90 Years
Healthy volunteers
No
Start date
15.09.2020
Completion date
30.12.2026
Registry ID
NCT04998175
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.